
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Kaynes Technology remains volatile amid repeated target revisions, a March 10 board meeting for compliance role changes, and market focus on valuation, working capital, and derivatives activity.
Vedanta shares moved lower after Foxconn ended their $19.5 billion semiconductor joint venture, even as Vedanta said it has lined up new partners for a chip foundry plan.
Sebi is in talks with CBDT on FPI signatory rules even as it rolls out SWAGAT-FI, longer validity, simpler KYC and a push to cut registration time.
GRSE shares jumped after Q4 FY26 profit and revenue growth, a ₹6.70 final dividend, and ICICI Direct comments on record FY26 execution and order book.
Ford shares logged their biggest single-day rally since 2020 after upbeat 2026 guidance and an energy-storage push, even as investors weighed Q4 weakness and supply risks.
India has extended restrictions on exporting multiple sugar categories beyond October 31, 2023 until further notice, while allowing limited quota shipments to select markets.
New UN and ILO assessments warn India could lose 5.8% of working hours by 2030, equating to 34 million full-time jobs, as heat stress hits outdoor work hardest.
Bajel Projects has won a Rs 200-300 crore domestic EPC contract from PGCIL’s SPV to build a 400 kV line supporting renewable energy evacuation in Karnataka.
DCM Shriram will hold a board meeting on May 12-13, 2026 to consider audited FY26 results and a final dividend, followed by an earnings call on May 15.
ZF Commercial Vehicle Control Systems India approved a 5:1 bonus issue, raised authorised capital to Rs 60 crore, and cleared a Rs 30 crore investment, alongside results and dividend agenda.
SEBI told banks and brokers they will not face tax liability for offshore fund clients, as CBDT simultaneously pushes disclosures of foreign assets ahead of a December 31, 2025 deadline.
Easy Trip Planners (EaseMyTrip) approved a rights issue of up to ₹500 crore, with issue terms pending, as the company targets expansion in hotels and holidays plus technology upgrades.
Metropolis Healthcare reported higher Q3FY26 profit and revenue, alongside strong B2B and B2C growth trends, with margins improving and acquisitions supporting expansion in core diagnostics.
Cipla says it will build a steady biosimilars pipeline, step up R&D for complex launches, and targets a $1 billion US run-rate by FY27 amid margin pressure.
Kaynes Technology reported March 2026 consolidated sales growth to ₹1,242.64 crore, while profit and EPS fell year-on-year amid higher depreciation and disclosure scrutiny.
Metropolis said Q4FY26 consolidated revenue grew 23% YoY, led by TruHealth wellness and specialised testing, ahead of a May 13 board meeting on audited results.